2016

NIH competition seeks wearable device to detect alcohol levels in real-time

Thursday, December 8, 2016

The National Institute on Alcohol Abuse and Alcoholism, part of the NIH, is once again challenging the biotech community to design a wearable device capable of measuring blood alcohol in near real-time. The ideal device would be capable of measuring alcohol concentration in the blood or interstitial fluid that surrounds the body’s cells, which differs from existing technology that detects alcohol released through the skin in sweat or vapor. The creators of the winning prototype will be awarded $200,000 and second place will receive $100,000 through Challenge.gov, which lists federal incentive prizes and competitions.

[Read More]

Charles River Laboratories launches CRISPR/Cas9 genome engineering technology

Thursday, December 8, 2016

Charles River Laboratories International has launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology. Through a licensing arrangement with the Broad Institute of MIT and Harvard, Charles River can now offer custom in vivo and in vitrogenome editing. With this technology, Charles River will be able to develop more translational research models that will ultimately improve the efficiency and effectiveness of the drug discovery process.

[Read More]

Center Point Clinical Services launches site-less CRO

Thursday, December 8, 2016

Center Point Clinical Services, creator of the Clinical Trial Research Pharmacist (CTRP) solution, has launched the world’s first site-less technology CRO. The site-less CRO model is designed to support the evolving world of clinical trials by empowering study sponsors to de-risk the clinical trial process, increase quality, reduce costs and ensure robust data for regulatory submissions.

[Read More]

Almac Group, inVentiv Health partner

Thursday, December 8, 2016

Almac Clinical Technologies, part of the Almac Group, a privately held contract pharmaceutical development and manufacturing organization, has announced the formation of a strategic partnership with inVentiv Health, a biopharma outsourcing company combining a leading CRO and the industry’s only contract commercial organization (CCO). The partnership presents an opportunity for both organizations to provide clients and sites with streamlined access to best-in-class clinical trial Interactive Response Technology (IRT) solutions.

[Read More]

NeuroCog Trials adds staff and office space

Monday, December 5, 2016

NeuroCog Trials, a cognitive services provider for the clinical trials industry, has announced that it is significantly expanding its presence at its headquarters in Durham. Construction is currently underway to give NeuroCog Trials the entire third floor, in addition to their fourth floor space of the SouthCourt building, totaling approximately 22,500 square feet of workspace.

[Read More]